RecruitingNCT07803185

Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor Agonists

Longitudinal Evaluation of Anhedonia and Emotional Eating Behavior in Individuals Using Glucagon-Like Peptide-1 Receptor Agonists

Sponsor

TC Erciyes University

Enrollment

60 participants

Start Date

Jun 1, 2026

Study Type

OBSERVATIONAL

Conditions

Obesity Anhedonia Emotional Eating

Summary

This prospective observational study evaluates the longitudinal changes in anhedonia levels and emotional eating behaviors among adult individuals initiating glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight loss. Participants are assessed at baseline (treatment initiation) and after a 6-month follow-up period using standardized psychometric instruments.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with anhedonia, emotional eating, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.